General
Preferred name
MK-912
Synonyms
L-657,743 ()
MK-912 hydrochloride ()
P&D ID
PD094241
CAS
111466-41-2
119942-70-0
Tags
available
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Selective alpha2A adrenoreceptor agonist (LOPAC library)
DESCRIPTION MK-912 is a potent new selective alpha 2-adrenergic receptor antagonist that is originated by Merck & Co for the treatment of Major depressive disorder. In Dec 1999, Phase-II clinical trials for Depression in USA was on going, but now it is discontinued. (BOC Sciences Bioactive Compounds)
Cell lines
0
Organisms
1
Compound Sets
4
BOC Sciences Bioactive Compounds
mk-912-hydrochloride-cas-119942-70-0-item-302665
Ki Database
L-657,743
LOPAC library
ReFrame library
External IDs
14
Properties
(calculated by RDKit )
Molecular Weight
339.19
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
0
Rotatable Bonds
0
Ring Count
5
Aromatic Ring Count
2
cLogP
3.25
TPSA
39.93
Fraction CSP3
0.55
Chiral centers
2.0
Largest ring
6.0
QED
0.74
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Selectivity
alpha2A
Solubility
Soluble in DMSO
Source data